BD antibiotic susceptibility testing discs recalled for accuracy failures
Becton Dickinson is recalling BD BBL Sensi Disc Ampicillin antibiotic susceptibility testing discs due to accuracy and quality control failures that may cause delayed diagnosis or inappropriate antibiotic selection.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall with no reported illnesses or injuries. The potential for testing accuracy failures affecting antibiotic susceptibility results could lead to delayed diagnosis and inappropriate antibiotic selection, representing significant patient care risk. Per rubric criteria for risk-of-harm products without reported injury, score is 3 (High).
Plain-English summary
Becton Dickinson & Co. is recalling BD BBL Sensi Disc Ampicillin antibiotic susceptibility testing discs (catalog numbers 230705, 231264, and 231263). The recall affects approximately 2,363,168 units distributed domestically and worldwide. The discs may have accuracy, reproducibility, or quality control failures that could impact test results.
These failures may cause delayed or inaccurate results in antibiotic susceptibility testing for H. influenzae. This could result in delayed diagnosis, selection of inappropriate antibiotics, or extended unnecessary antibiotic exposure. No illnesses or injuries have been reported.
Healthcare facilities and laboratories using these discs should immediately discontinue use of affected lots. Contact Becton Dickinson for replacement or instructions. Specific lot numbers are available on the FDA recall notification.
The recalled product
- Product
- BD BBL Sensi Disc Ampicillin - 10 ¿g, Catalog No. 230705 and 231264; 2 ¿g, Catalog No. 231263. Used for semi-quantitative in vitro susceptibility testing.
- Manufacturer
- Becton Dickinson & Co.
- Affected units
- 2,363,168
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 30 recalled by Becton Dickinson & Co. under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 30 products in this recall →Related recalls
Same manufacturer · Becton Dickinson & Co.
See all →- ModerateBD GasPak EZ Campy Pouch System Recall for Below-Specification Gas Production
FDA (Devices) · 2026-05-06
- ModerateBD GasPak EZ CO2 Pouch System gas generating sachets underperforming
FDA (Devices) · 2026-05-06
- ModerateLaboratory cuvette arrays recalled over barcodes the analyser cannot read
FDA (Devices) · 2025-11-19
- HighAutomated microbiology systems recalled after service credentials were accessed by unauthorized actor
FDA (Devices) · 2025-10-29
- HighBlood culture systems recalled after service credentials were accessed by unauthorized actor
FDA (Devices) · 2025-10-29
Same hazard · accuracy failure
See all →- HighBD BBL Ertapenem Susceptibility Test Discs Recalled for Accuracy Failures
FDA (Devices) · 2024-02-14
- HighBD BBL Sensi Disc Meropenem testing discs recalled for accuracy failures
FDA (Devices) · 2024-02-14
- HighBD BBL Sensi Disc Antibiotic Test Discs Recalled for Accuracy Failures
FDA (Devices) · 2024-02-14
- HighBD Sensi Disc Cefpodoxime Antibiotic Testing Discs Recalled for Accuracy Failures
FDA (Devices) · 2024-02-14
- HighLab testing discs recalled for potential antibiotic susceptibility testing failures
FDA (Devices) · 2024-02-14